Clinical trials on gastrointestinal cancer in Western Europe and in the FORTC.
The therapeutics on gastrointestinal cancer including only randomized clinical trials carried out in Western Europe and in the EORTC are reported. The studies on preoperative radiotherapy in resectable esophagus cancer and on chemotherapy associated to radiotherapy in nonresectable esophagus cancer has just been activated. The data of a trial on the treatment of gastric cancer have demonstrated the efficacy of long term 5-FU administered after postoperative irradiations. A trial on the immunostimulating effect of levamisole as adjuvant treatment of colon cancer is described, as well as the results of chemotherapy in advanced colon cancer. Finally, scribed, as well as the results of chemotherapy in advanced colon cancer. Finally, the preliminary results of two European trials studying the effect of preoperative radiotherapy and of a chemotherapy, used as a preoperative irradiation sensitizer in rectal cancer, are commented on.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D003110:Colonic Neoplasms / Q000628:therapy; D004938:Esophageal Neoplasms / Q000628:therapy; D005060:Europe; D005770:Gastrointestinal Neoplasms / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy; D012004:Rectal Neoplasms / Q000628:therapy; D013274:Stomach Neoplasms / Q000628:therapy
D000970:Antineoplastic Agents